WESTERN STATE HOSPITAL
1. Target Overview & Investment Thesis
WESTERN STATE HOSPITAL is a 84-bed community hospital in AUGUSTA, VA with $4.7M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 7.9% Medicare, 0.0% Medicaid, and 92.1% commercial.
Thesis: Turnaround. Our ML models identify $356K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -1673.5% (+762bps).
| Net Revenue HCRIS | $4.7M |
| Current EBITDA COMPUTED | $-78.6M |
| Operating Margin COMPUTED | -100.0% |
| Occupancy HCRIS | 71.9% |
| Revenue / Bed COMPUTED | $56K |
| Net-to-Gross HCRIS | 5.1% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of -100.0% places it below the state median. Among 53 size-comparable peers (42-168 beds), the median margin is 5.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (42-168), prioritizing same-state peers. 53 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| WESTERN STATE HOSPITAL (Target) | VA | 84 | $4.7M | -100.0% |
| SENTARA MARTHA JEFFERSON HOSPI | VA | 150 | $362.0M | -6.4% |
| MARYVIEW HOSPITAL | VA | 160 | $348.0M | -2.5% |
| ST. FRANCIS MEDICAL CENTER | VA | 128 | $339.6M | 8.6% |
| SENTARA NORTHERN VIRGINIA MED | VA | 147 | $286.3M | -4.3% |
| INOVA MOUNT VERNON HOSPITAL | VA | 140 | $263.2M | 17.7% |
| CARILION NEW RIVER VALLEY MED | VA | 94 | $261.3M | -0.5% |
| RICHMOND COMMUNITY HOSPITAL | VA | 96 | $254.9M | 21.5% |
| SENTARA WILLIAMSBURG REGIONAL | VA | 123 | $192.2M | -4.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $356K (762bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Denial Rate Reduction | 12.0% | 6.5% | $98K | +210bp | 12mo |
| Net Collection Rate | 93.5% | 97.0% | $98K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $93K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $57K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +21bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-78.6M |
| + RCM Uplift | +$356K |
| Pro Forma EBITDA | $-78.2M |
| Current Margin | -100.0% |
| Pro Forma Margin | -1673.5% |
| WC Released (1x) | $179K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-120.9M | $-514.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-120.9M | $-605.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-108.8M | $-643.7M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-108.8M | $-734.3M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-133.0M | $-477.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-133.0M | $-568.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 53 hospitals with 42-168 beds
- Same-state prioritization (n=54)
- Comp margins: P25=-6.4% / P50=5.2% / P75=14.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.